Browsing Centre for Clinical Trials & Methodology by Author "Brunt, AM"
Now showing items 1-7 of 7
-
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Velikova, G; Morden, JP; Haviland, JS; Emery, C; Barrett-Lee, P; Earl, H; Bloomfield, D; Brunt, AM; Canney, P; Coleman, R (2023-12)BACKGROUND: Adjuvant chemotherapy for patients with early breast cancer improves outcomes but its toxicity affects patients' quality of life (QOL). The UK TACT2 trial investigated whether accelerated epirubicin improves ... -
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis
Glynn, D; Bliss, J; Brunt, AM; Coles, CE; Wheatley, D; Haviland, JS; Kirby, AM; Longo, F; Faria, R; Yarnold, JR (2023) -
Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation
Brunt, AM; Haviland, JS; Kirby, AM; Somaiah, N; Wheatley, DA; Bliss, JM; Yarnold, JR (2021) -
Hypofractionation: The standard for external beam breast irradiation.
Brunt, AM; Haviland, JS (2023-06)This overview provides the historical perspective of external beam breast hypofractionation over the last 50 years. It highlights the serious harm suffered by patients with breast cancer in the 1970's and 1980's because ... -
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt, AM; Haviland, JS; Wheatley, DA; Sydenham, MA; Bloomfield, DJ; Chan, C; Cleator, S; Coles, CE; Donovan, E; Fleming, H (2023-11)BACKGROUND: FAST-Forward aimed to identify a 5-fraction schedule of adjuvant radiotherapy delivered in 1 week that was non-inferior in terms of local cancer control and as safe as the standard 15-fraction regimen after ... -
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
Brunt, AM; Haviland, JS; Sydenham, M; Agrawal, RK; Algurafi, H; Alhasso, A; Barrett-Lee, P; Bliss, P; Bloomfield, D; Bowen, J (2020) -
When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management.
Obeng-Gyasi, S; Coles, CE; Jones, J; Sacks, R; Lightowlers, S; Bliss, JM; Brunt, AM; Haviland, JS; Kirby, AM; Kalinsky, K (2021-03)In the care of patients with operable breast cancer, there has been a shift toward increasing use of neoadjuvant therapy. There are benefits to neoadjuvant therapy, such as monitoring for response, as well as an increased ...